Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, comparative and prospective clinical trial evaluating efficacy and safety of a dose of seasonal flu vaccine compared to two doses of vaccine for prevention of influenza in solid organ transplant recipients Ensayo clínico prospectivo aleatorizado comparativo de la eficacia y seguridad de una dosis de vacuna estacional respecto a dos dosis de vacunas como prevención de la gripe en receptores de trasplante de órgano sólido

Next Previous
Trial Profile

Randomized, comparative and prospective clinical trial evaluating efficacy and safety of a dose of seasonal flu vaccine compared to two doses of vaccine for prevention of influenza in solid organ transplant recipients Ensayo clínico prospectivo aleatorizado comparativo de la eficacia y seguridad de una dosis de vacuna estacional respecto a dos dosis de vacunas como prevención de la gripe en receptores de trasplante de órgano sólido

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms TraNsgripe

Most Recent Events

  • 01 May 2015 Biomarkers information updated
  • 04 Nov 2013 Planned number of patients changed from 508 to 499 as reported by ClinicalTrials.gov.
  • 03 Jan 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01761435).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top